Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Nutex Health (NUTX) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Nutex Health (NUTX) over the last 16 years, with Q3 2025 value amounting to $3.3 million.

  • Nutex Health's Cost of Revenue fell 1697.21% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year decrease of 1218.29%. This contributed to the annual value of $15.3 million for FY2024, which is 801.59% up from last year.
  • Nutex Health's Cost of Revenue amounted to $3.3 million in Q3 2025, which was down 1697.21% from $4.8 million recorded in Q2 2025.
  • Nutex Health's Cost of Revenue's 5-year high stood at $5.3 million during Q1 2024, with a 5-year trough of $1.6 million in Q1 2021.
  • For the 5-year period, Nutex Health's Cost of Revenue averaged around $3.4 million, with its median value being $3.4 million (2023).
  • The largest annual percentage gain for Nutex Health's Cost of Revenue in the last 5 years was 224381.21% (2021), contrasted with its biggest fall of 7349.48% (2021).
  • Nutex Health's Cost of Revenue (Quarter) stood at $2.6 million in 2021, then grew by 7.43% to $2.8 million in 2022, then rose by 21.89% to $3.4 million in 2023, then dropped by 29.72% to $2.4 million in 2024, then soared by 38.28% to $3.3 million in 2025.
  • Its Cost of Revenue stands at $3.3 million for Q3 2025, versus $4.8 million for Q2 2025 and $3.8 million for Q1 2025.